TSUMURA & CO ORDINARY SHARES (OTCMKTS:TSMRF) had a decrease of 2.25% in short interest. TSMRF’s SI was 108,700 shares in May as released by FINRA. Its down 2.25% from 111,200 shares previously. It closed at $35.28 lastly. It is down 0.00% since May 16, 2017 and is . It has underperformed by 11.55% the S&P500.
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products in Japan, China, and internationally. The company has market cap of $2.72 billion. The firm primarily provides prescription Kampo products covered under the Japanese national health insurance plan, as well as OTC Kampo products. It currently has negative earnings. It is also developing TU-100 (Daikenchuto), which is in Phase II clinical trials for the treatment of irritable bowel syndrome, postoperative ileus, and Crohn's disease in the United States.
As exposed in an electronic document that was submitted to the U.S. Security and Exchange Commission on May 15, 2018, Brien Chase, Chief Financial Officer of Premier Financial Bancorp Inc and an insider with a special knowledge about the company, sold 400 shares of the company for the sum of $8,400 US Dollars based on an average price per share of $21.0. Brien Chase now owns 20,849 shares of the Firm.
The stock increased 3.72% or $0.77 during the last trading session, reaching $21.47. About 8,319 shares traded. Premier Financial Bancorp, Inc. (NASDAQ:PFBI) has declined 3.19% since May 16, 2017 and is downtrending. It has underperformed by 14.74% the S&P500.
Premier Financial Bancorp, Inc., a multi-bank holding company, provides community banking services to individuals and small-to-medium sized businesses. The company has market cap of $229.38 million. The firm accepts various deposit products, including checking, NOW, savings, money market, club, individual retirement, and overdraft protection accounts, as well as certificates of deposit. It has a 15.56 P/E ratio. The Company’s loan products include loans for purchasing personal residences or loans for commercial or consumer purposes secured by residential mortgages; financing for automobile; personal loans, such as unsecured lines of credit; commercial loans that are secured by business assets consisting of real estate, equipment, inventory, and accounts receivable; real estate development loans; commercial real estate loans; and agricultural loans.
Investors sentiment increased to 2.58 in 2017 Q4. Its up 1.08, from 1.5 in 2017Q3. It increased, as 2 investors sold Premier Financial Bancorp, Inc. shares while 10 reduced holdings. 6 funds opened positions while 25 raised stakes. 3.21 million shares or 4.32% more from 3.07 million shares in 2017Q3 were reported. Tower Research Capital Lc (Trc) reported 120 shares or 0% of all its holdings. Tiaa Cref Invest Management Llc holds 0% or 25,863 shares in its portfolio. Wells Fargo Mn, California-based fund reported 15,758 shares. American Gp accumulated 0% or 6,339 shares. Sei Invs has 220 shares. New York-based Bankshares Of Ny Mellon Corp has invested 0% in Premier Financial Bancorp, Inc. (NASDAQ:PFBI). California State Teachers Retirement invested in 0% or 14,886 shares. Meeder Asset Mngmt has invested 0% of its portfolio in Premier Financial Bancorp, Inc. (NASDAQ:PFBI). Bnp Paribas Arbitrage reported 2,697 shares stake. Geode Cap Management invested in 50,510 shares. Bridgeway Capital Mgmt invested 0.02% in Premier Financial Bancorp, Inc. (NASDAQ:PFBI). 44,470 are owned by Martingale Asset Mgmt Ltd Partnership. The Massachusetts-based Baystate Wealth has invested 0% in Premier Financial Bancorp, Inc. (NASDAQ:PFBI). Citigroup stated it has 5,614 shares or 0% of all its holdings. Ny State Common Retirement Fund accumulated 10,549 shares.
Another recent and important Premier Financial Bancorp, Inc. (NASDAQ:PFBI) news was published by Benzinga.com which published an article titled: “Premier Financial Bancorp, Inc. Announces Agreement To Purchase First Bank Of Charleston” on April 19, 2018.